Skip to main content

Animations

MJFF Publications

3541 - 3550 of 8673 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: Deciphering DDX3X Syndrome to Capture Determinants of Intellectual Disability
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.02.969
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Cross-Platform Comparison of Immunoassay Technologies to Assess Cytokine Markers in Patients With Post-Traumatic Stress Disorder and Parkinson’s Disease
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.02.968
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Cortical Thickness, Neurocognition and Social Cognition in Euthymic Individuals With Bipolar Disorder and Their Healthy Siblings
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.02.967
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Aggressiveness after centromedian nucleus stimulation engages prefrontal thalamocortical circuitry
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2019.10.023
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Human plasma biomarker responses to inhalational general anaesthesia without surgery
    Journal Name: British Journal of Anaesthesia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bja.2020.04.085
    Citation Count: 40
  • Summary Details
    RESTRICTED
    Title: Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation
    Journal Name: Cancer Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.canlet.2020.07.015
    Best OA location URL:
    Citation Count: 17
  • Summary Details
    OPEN
    Title: TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson’s Disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2020.108418
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2020.107807
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Personalized care management for persons with Parkinson's disease: A telenursing solution
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100070
    Citation Count: 10
  • Summary Details
    OPEN
    Title: PDmethDB: A curated Parkinson’s disease associated methylation information database
    Journal Name: Computational and Structural Biotechnology Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.csbj.2020.11.015
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.